Kenalog Spray Generic Name & Formulations
Triamcinolone acetonide 0.2%.
Kenalog Spray Indications
Kenalog Spray Dosage and Administration
Adults and Children
Apply sparingly 3–4 times daily.
Kenalog Spray Contraindications
Kenalog Spray Boxed Warnings
Kenalog Spray Warnings/Precautions
Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Use lowest effective dose and potency (esp. in children). Flammable. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Kenalog Spray Pharmacokinetics
Kenalog Spray Interactions
Kenalog Spray Adverse Reactions
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.
Kenalog Spray Clinical Trials
Kenalog Spray Note
Kenalog Spray Patient Counseling